Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas

• Roopesh Kansara,
• Joseph M. Connors,
• Kerry J. Savage,
• Alina S. Gerrie,
• David W. Scott,
• Graham W. Slack,
• Randy D. Gascoyne,
• Laurie H. Sehn,
• Diego Villa

Affiliations

Roopesh Kansara

Centre for Lymphoid Cancer and Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada

Joseph M. Connors

Centre for Lymphoid Cancer and Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada

Kerry J. Savage

Centre for Lymphoid Cancer and Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada

Alina S. Gerrie

Centre for Lymphoid Cancer and Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada;Leukemia/Bone Marrow Transplant Program of British Columbia, British Columbia Cancer Agency, Vancouver, BC, Canada

David W. Scott

Centre for Lymphoid Cancer and Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada

Graham W. Slack

Centre for Lymphoid Cancer and Department of Pathology and Laboratory Medicine, British Columbia Cancer Agency, Vancouver, BC, Canada

Randy D. Gascoyne

Centre for Lymphoid Cancer and Department of Pathology and Laboratory Medicine, British Columbia Cancer Agency, Vancouver, BC, Canada

Laurie H. Sehn

Centre for Lymphoid Cancer and Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada

Diego Villa

Centre for Lymphoid Cancer and Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada